Infinity Pharma 3Q Loss Narrows On Payments

Stock quotes in this article: INFI  

CAMBRIDGE, Mass. (AP) — Infinity Pharmaceuticals Inc. said Monday its third-quarter loss narrowed on a boost in payments from its partnership with Purdue Pharmaceutical Products LP and Mundipharma International Corp.

The company lost $9.3 million, or 36 cents per share, compared with a loss of $12.4 million, or 63 cents per share, during the same period a year prior. Revenue surged to $13.8 million from $2.5 million.

Analysts polled by Thomson Reuters expected a loss of 44 cents per share on revenue of $12.4 million.

Infinity has several compounds in development, aimed at various types of cancer.

Shares of Infinity added 5 cents to $5.78 in morning trading Tuesday.

  • Loading Comments...
  •  

SHARE:

  • email
  • print
  • comment
  • digg
  • delicious
  • linkedin
Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Recent Comments





Connect with TheStreet

Dow Jones S&P 500 NASDAQ 10-Year Note
10,464.40 1,110.63 2,176.05 32.79
Oil *
77.05
UP
30.69
UP
4.98
UP
6.87
DOWN
0.38
10 Yr
3.28%
SPDR Gold
116.62
+0.29%
+0.45%
+0.32%
-1.15%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services